Jiang et al showed that IL‐13 increases glucose oxidation in skeletal muscle myotubes from diabetic and nondiabetic patients.40 IL‐13 deficiency in mice leads to increased weight gain, hyperglycemia, and hepatic insulin resistance due to the dysregulation of the IL‐13Rα1/STAT3 axis in hepatocytes.41 Together, our findings could be relevant for the development of new therapies for diabetic cardiomyopathy. The gene discussed is IL13; the disease is diabetic cardiomyopathy.